Research Article

Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol

Table 2

Myeloid antigen expression in childhood acute lymphoblastic leukemia in Yogyakarta, Indonesia.

VariablePatients (%) 
Myeloid positive
(%)
Myeloid negative
(%)
value

60 (25)179 (75)
Sex
  Male139 (58) 37 (27) 102 (73)0.52
  Female100 (42)23 (23) 77 (77)
Age
  1–9 years188 (79)49 (26)139 (74)0.51
  <1 & 10–14 yrs51 (21)11 (22) 40 (78)
White blood cell count
  <50.000/mm3185 (77)47 (25)138 (75)0.84
  >50.000/mm354 (23)13 (24) 41 (76)
French-American-British classification
  ALL-L1198 (83)44 (22)154 (78)0.02
  ALL-L241 (17)16 (39) 25 (61)
Immunophenotyping
  B-lineage183 (77)50 (27)133 (73)0.15
  T-lineage56 (23)10 (18) 46 (82)
Risk classification (NCI based)
  Standard risk95 (40)29 (31) 66 (69)0.17
  High risk144 (60)31 (22) 113 (79)